StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.31−0.68 (-17.04%)

Close on Nov 17, 2026Market cap $30.72MP/E –Yield –

Exozymes market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Exozymes's market cap was $37.13M on Nov 11, 2026, against $133.11M a year earlier. Over the last 2 years it ranged from $37.13M to $141.42M, with a median of $83.90M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$37.13M-59.4%
2025Dec 31, 2025$91.42M-11.4%
2024Dec 31, 2024$103.16M–

More Exozymes figures

See a number that looks wrong?